← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oncoc4, Inc.
Rockville, MD
$2,000,000
Total funding
1
Grants
Funding over time
peak $1M · FY2021–22$1M$750K$500K$250K$0
'21
'22
Funding mix
By agency
NIH$2,000,000 · 1
By mechanism
R44$2,000,000 · 1
Investigators at Oncoc4, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy$1,000,000
R44 · FY2021 · CA
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy$1,000,000
R44 · FY2022 · CA